Covid-19: Scientists to trial oral Covid vaccine pills
The company hoped to begin phase one trials of the pills in humans by June.
Scientists are looking to trial Covid vaccines which exist in pill form this year.
According to Business Insider, Oravax, a joint venture by the Israeli-American company Oramed and the Indian company Premas Biotech, stated that it hoped to begin the first phase of clinical human trials by June this year.
An oral vaccine could "potentially [enable] people to take the vaccine themselves at home," Nadav Kidron, CEO of Oramed, said in the release.
“The vaccine could be shipped in a normal refrigerator and stored at room temperature, making it logistically easier to get it anywhere around the world."
This makes it a more scalable, easier to distribute and simpler to administer the vaccine, especially for those who are “severely needle-phobic,” said Paul Hunter, Professor in Medicine at the University of East Anglia.
"We would need properly conducted studies to prove [oral vaccines'] worth," he said.
Other forms of second-generation vaccines are being looked into, including a nasal spray and patches.
Prime Minister Narendra Modi urged officials to ensure seamless and... READ MORE
India's crisis highlights the need to increase investment in the... READ MORE
Measures taken by government successful in controlling spread of the ... READ MORE
Previous studies had shown it was linked to a higher likelihood of... READ MORE
The 21-year-old already has a history of criminal behaviour. READ MORE
'To ensure a smooth traffic flow and the safety of the public' READ MORE
India's megapolis reports a 65% spike in cases among kids since March ... READ MORE
Restaurants can continue to offer food delivery services to their... READ MORE